Antiangiogenic Agents After First Line and Sorafenib Plus Chemoembolization: A Systematic Review

Oncotarget - United States
doi 10.18632/oncotarget.19449
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Transcatheter Arterial Chemoembolization After Stopping Sorafenib Therapy for Advanced Hepatocellular Carcinoma

PLoS ONE
Multidisciplinary
2017English

Safety and Efficacy of Transcatheter Arterial Chemoembolization Plus Radiotherapy Combined With Sorafenib in Hepatocellular Carcinoma Showing Macrovascular Invasion

Frontiers in Oncology
Cancer ResearchOncology
2019English

Reconsidering First-Line Treatment for Obstructive Sleep Apnea: A Systematic Review of the Literature

Journal of Otolaryngology - Head and Neck Surgery
OtorhinolaryngologySurgery
2016English

Is Scheduled Second Chemoembolization Necessary for Early Stage Hepatocellular Carcinoma Showing Complete Response After First Chemoembolization?

Clinical and molecular hepatology
MedicineHepatologyMolecular Biology
2017English

Comparative Effectiveness of Fourth-Line Anti-Hypertensive Agents in Resistant Hypertension: A Systematic Review and Meta-Analysis

European Journal of Preventive Cardiology
EpidemiologyCardiovascular MedicineCardiology
2016English

Lipiodol Transarterial Chemoembolization for Hepatocellular Carcinoma: A Systematic Review of Efficacy and Safety Data

Hepatology
MedicineHepatology
2016English

Antiangiogenic Agents in Cancer Therapy

Journal of the Royal Society of Medicine
Medicine
1999English

Is Nonoperative Management the Best First-Line Option for High-Grade Renal Trauma? A Systematic Review

European Urology Focus
Urology
2019English

Pcn165 - Cost-Effectiveness of Sorafenib for Metastatic Renal Cell Carcinoma: A Systematic Review

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy